$HELP

3 theses

bullish 100%neutral 0%bearish 0%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$HELPSEC 13Dbullish

So Eric H. L. · beneficial owner of Cybin Inc. · 21d agono track record yet

Long 4,423,894 shares of HELP

4,423,894 shares · 5.8% of class · 2026-09-01

Schedule 13D: So Eric H. L. disclosed a stake in HELP

So Eric H. L. disclosed a 5.8% stake of 4,423,894 shares in Cybin Inc. (HELP) in a Schedule 13D filed 2026-09-09.

At post $13.68Now $12.37-9.6% since postedas of Sep 18, 4:30 PM ET

1d-6.1%

3d-5.2%

1w-1.5%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$HELPSEC 13Dbullish

Glavine Paul · beneficial owner of Cybin Inc. · 22d agono track record yet

Long 4,407,456 shares of HELP

4,407,456 shares · 5.8% of class · 2026-09-01

Schedule 13D: Glavine Paul disclosed a stake in HELP

Glavine Paul disclosed a 5.8% stake of 4,407,456 shares in Cybin Inc. (HELP) in a Schedule 13D filed 2026-09-09.

At post $13.68Now $12.37-9.6% since postedas of Sep 18, 4:30 PM ET

1d-6.1%

3d-5.2%

1w-1.5%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$HELPr/wallstreetbetsYOLObullish

u/Zestyclose_Walrus292 · 98d agono track record yet

“$HELP YOLO (position details not specified)”

I might need some $HELP after this psychedelic yolo

Author has a YOLO position in HELP driven by stellar Phase 2 results, FDA Breakthrough designation, and high-level regulatory support. The drug class is validated, and the stock trades near cash with massive potential upside from peer multiples.

At post $5.09Now $12.37+143.0% since postedas of Sep 18, 4:30 PM ET

1d+18.3%

3d+27.3%

1w+23.4%

1m+49.7%

3m—

6m—

1y—

original post →

End of results.